# 2025年12月23日 - 专业文献速递

本期速递为您整理了最新的科研文献及AI评价，每一篇文献都包含了详细的元数据、原文摘要、中文翻译和AI的专业点评，敬请参考。

---

## 1. 针对结核病患者的移动健康戒烟干预：是时候从探索走向实施了

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41428296)
**期刊：** JAMA
**PMID：** 41428296
**DOI：** 10.1001/jama.2025.23909

### 第一部分 原文与翻译

**英文原标题：** mHealth Smoking Cessation Treatment for People With Tuberculosis: Time to Move From Exploration to Implementation.

> **英文摘要：**
> No abstract available.

> **中文摘要：**
> 无摘要可用。

### 第二部分 AI 大师评价

本研究标题表明作者呼吁将移动健康（mHealth）用于结核病患者的戒烟干预，从理论和探索阶段过渡到实际应用与推广阶段。尽管缺乏摘要可供分析，但可以推测研究聚焦于如何利用数字健康工具改善结核病患者的戒烟率，从而促进治疗效果与公众健康收益。该议题具有高度公共卫生意义和现实可行性，突出了技术转化和健康行为干预的结合。然而，若缺乏实证结果或实施策略细节，其应用价值仍需进一步验证。

---

## 2. 社区起病脓毒症住院成人的抗生素降阶治疗

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41428290)
**期刊：** JAMA internal medicine
**PMID：** 41428290
**DOI：** 10.1001/jamainternmed.2025.6919

### 第一部分 原文与翻译

**英文原标题：** Antibiotic De-Escalation in Adults Hospitalized for Community-Onset Sepsis.

> **英文摘要：**
> IMPORTANCE: Prolonged exposure to broad-spectrum antibiotics (BSA) may be associated with patient harm.
> 
> OBJECTIVE: To assess outcomes of BSA de-escalation compared with continuation on encounter day 4 in patients hospitalized for community-onset sepsis.
> 
> DESIGN, SETTING, AND PARTICIPANTS: This target trial emulation study was conducted at 67 hospitals participating in the Michigan Hospital Medicine Safety Consortium. Patients 18 years and older hospitalized for community-onset sepsis from June 2020 through September 2024 who initiated empiric BSA therapy without evidence of multidrug-resistant organism infection were included. Data were analyzed from September 2024 to November 2025.
> 
> EXPOSURE: Inverse probability of treatment-weighted cohort exposed to de-escalation of BSA vs continuation at day 4.
> 
> MAIN OUTCOMES AND MEASURES: The primary outcome was 90-day all-cause mortality. Secondary outcomes included in-hospital mortality, 30-day mortality, length of hospitalization, and days of antibiotic therapy.
> 
> RESULTS: Among 36 924 patients with community-onset sepsis, 18 559 (50.3%) were female, 18 365 (49.7%) were male, and the median (IQR) age was 71 (61-80) years. A total of 6926 (18.8%) and 11 149 (30.2%) were eligible for target trial emulations evaluating de-escalation of anti-methicillin-resistant Staphylococcus aureus (MRSA) and anti-Pseudomonas aeruginosa (PSA; or other resistant gram-negative bacteria) antibiotics, respectively. Of these, 2993 (43.2%) and 2493 (22.4%) were de-escalated from anti-MRSA and anti-PSA coverage. After weighting, patients who were de-escalated vs continued on BSA were well balanced on baseline characteristics. In weighted analyses, anti-MRSA and anti-PSA de-escalation were associated with similar 90-day mortality as continued BSA therapy (anti-MRSA: odds ratio, 1.00; 95% CI, 0.88-1.14; anti-PSA: odds ratio, 0.98; 95% CI, 0.86-1.13). Additionally, anti-MRSA and anti-PSA de-escalation were associated with fewer days of antibiotics to day 14 (anti-MRSA de-escalation: risk ratio [RR], 0.91; 95% CI, 0.89-0.93; anti-PSA de-escalation: RR, 0.91; 95% CI, 0.88-0.93) and shorter length of hospitalization (anti-MRSA de-escalation: RR, 0.88; 95% CI, 0.85-0.92; anti-PSA de-escalation: RR, 0.91; 0.88-0.93). All other secondary outcomes were similar. Across 67 hospitals, the proportion of eligible patients de-escalated from BSA varied more than 2-fold (anti-MRSA de-escalation, 27.3% to 61.7%; anti-PSA de-escalation, 6.9% to 37.7%).
> 
> CONCLUSIONS AND RELEVANCE: In this study, de-escalation of empiric BSA therapy at day 4 was associated with similar safety outcomes, fewer antibiotic days, and shorter length of hospitalization among patients with community-onset sepsis compared with those who continued BSA therapy but varied widely in practice.

> **中文摘要：**
> 重要性：长期使用广谱抗生素（BSA）可能与患者的不良结局相关。
> 
> 研究目的：评估在社区起病脓毒症住院患者中，于入院第4天实施广谱抗生素降阶治疗与继续使用相比的结局。
> 
> 研究设计、地点与参与者：本研究为目标试验仿真研究，在参与密歇根医院内科安全联盟的67家医院开展。纳入2020年6月至2024年9月期间，年龄≥18岁、因社区起病脓毒症住院且启动经验性广谱抗生素治疗但无多重耐药菌感染证据的患者。数据分析时间为2024年9月至2025年11月。
> 
> 暴露因素：基于逆概率加权法的队列，用以比较第4天实施广谱抗生素降阶治疗与继续治疗的患者。
> 
> 主要结局和测量指标：主要结局为90天全因死亡率。次要结局包括住院死亡率、30天死亡率、住院时长以及抗生素使用天数。
> 
> 结果：在36,924名社区起病脓毒症患者中，18,559人（50.3%）为女性，18,365人（49.7%）为男性，中位年龄（四分位间距）为71岁（61–80岁）。共有6,926人（18.8%）和11,149人（30.2%）分别符合纳入抗耐甲氧西林金黄色葡萄球菌（MRSA）和抗铜绿假单胞菌（PSA，或其他耐药革兰阴性菌）降阶治疗仿真评估的标准。其中，2,993人（43.2%）和2,493人（22.4%）分别接受了抗MRSA和抗PSA覆盖的降阶治疗。加权后，降阶组与继续广谱抗生素组的基线特征平衡良好。加权分析显示，抗MRSA和抗PSA降阶治疗的患者，其90天死亡率与继续BSA治疗者相似（抗MRSA：比值比1.00；95%置信区间0.88–1.14；抗PSA：比值比0.98；95%置信区间0.86–1.13）。此外，抗MRSA和抗PSA降阶治疗组在14天内的抗生素使用天数更少（抗MRSA降阶：风险比[RR] 0.91；95%置信区间0.89–0.93；抗PSA降阶：RR 0.91；95%置信区间0.88–0.93），且住院时间更短（抗MRSA降阶：RR 0.88；95%置信区间0.85–0.92；抗PSA降阶：RR 0.91；95%置信区间0.88–0.93）。其他次要结局相似。在67家医院中，符合条件患者的降阶比例存在两倍以上差异（抗MRSA降阶：27.3%–61.7%；抗PSA降阶：6.9%–37.7%）。
> 
> 结论与意义：本研究显示，在社区起病脓毒症住院患者中，于第4天实施经验性广谱抗生素降阶治疗与继续使用相比，可获得相似的安全结局，同时缩短抗生素疗程和住院时间，但各医院实践差异较大。

### 第二部分 AI 大师评价

该研究通过目标试验仿真方法，评估了社区起病脓毒症患者在第4天实施广谱抗生素降阶治疗的有效性和安全性。研究覆盖67家医院的大样本患者，发现降阶组在保持相似死亡率的同时，显著减少了抗生素使用天数并缩短了住院时间。研究创新地利用真实世界数据验证了抗生素管理策略的可行性，为抗生素合理使用提供了量化依据。其局限在于尽管采用加权平衡，但仍可能存在残余混杂及不同医院间实践差异。

---

## 3. 危重症中的分步液体管理

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41428209)
**期刊：** Intensive care medicine
**PMID：** 41428209
**DOI：** 10.1007/s00134-025-08263-8

### 第一部分 原文与翻译

**英文原标题：** Stepwise fluid management in critical illness.

> **英文摘要：**
> No abstract available.

> **中文摘要：**
> 无可用摘要。

### 第二部分 AI 大师评价

本研究题目聚焦于危重症患者的分阶段液体管理策略，旨在优化液体复苏与限制之间的平衡。尽管无摘要可供分析，但可推测文章可能探讨在不同病程阶段如何动态调整液体治疗，以改善组织灌注与预防液体过负荷。该主题在重症医学中具有重要的临床指导价值，可为精准液体管理提供新的思路。研究的创新性可能在于建立系统化、可操作的液体管理路径，但其临床验证或实践可行性仍需进一步研究。

---

## 4. 重症与重症后护理全程中老年患者照护的挑战与策略

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41428207)
**期刊：** Intensive care medicine
**PMID：** 41428207
**DOI：** 10.1007/s00134-025-08253-w

### 第一部分 原文与翻译

**英文原标题：** Challenges and strategies in the care of older adults across the continuum of intensive and post-intensive care medicine.

> **英文摘要：**
> Older adults have composed more than half of ICU patient-days for the past 25 years, and these numbers are only expected to grow as the worldwide population of older adults doubles by 2050. For older adults, conditions such as frailty, disability in functional activities, and multimorbidity are more strongly associated with ICU and post-ICU outcomes than chronological age, and recent work shows that the prevalence of these conditions among older ICU patients is increasing over time. In response to this demographic shift, the science of aging-focused critical care has rapidly expanded over the past decade, and we now know more about how to care for older ICU patients than ever before. However, challenges in the care of older adults across the continuum of ICU and post-ICU care remain. In this narrative review, we discuss these challenges, propose strategies and future research to address them, and discuss best practices for the care of older ICU patients in the context of the state of the science.

> **中文摘要：**
> 在过去的25年中，老年患者已占重症监护病房（ICU）患者日数的一半以上，且随着全球老年人口到2050年预计将翻倍，这一比例预计还会继续上升。对于老年患者而言，虚弱、日常功能障碍以及多重共病等状况，与ICU及重症后期（post-ICU）的结局相比单纯的年龄更为密切相关，且近期研究显示，这些状况在老年ICU患者中的患病率正随时间上升。面对这一人口学转变，聚焦老年医学的重症医学研究在过去十年中迅速发展，我们现在对如何照护老年ICU患者的认识比以往任何时候都更加深入。然而，在ICU及重症后护理全程中老年患者的照护仍面临诸多挑战。本文作为一篇叙述性综述，讨论了这些挑战，提出应对策略与未来研究方向，并在当代科学进展的背景下探讨老年ICU患者照护的最佳实践。

### 第二部分 AI 大师评价

本文通过综述方式系统探讨了老年患者在重症及重症后护理全程中面临的主要挑战与策略。作者指出老年患者的虚弱、多病共存及功能障碍是影响预后的关键因素，而不仅仅是年龄本身。文章强调老年重症护理科学的迅速发展，并提出未来研究与临床实践需进一步针对个体化、多学科整合的照护路径。其创新性在于将重症与重症后期连续护理作为整体过程审视，体现出老年医学与重症医学融合的趋势。

---

## 5. PEEP 对脑损伤患者颅内压的影响及其与病因学的关系

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41428206)
**期刊：** Intensive care medicine
**PMID：** 41428206
**DOI：** 10.1007/s00134-025-08222-3

### 第一部分 原文与翻译

**英文原标题：** Effects of PEEP on ICP in ABI patients and its relationship with etiology.

> **英文摘要：**
> No abstract available.

> **中文摘要：**
> 暂无可用摘要。

### 第二部分 AI 大师评价

该研究旨在探讨呼气末正压（PEEP）对急性脑损伤（ABI）患者颅内压（ICP）的影响，并分析其与基础病因之间的关系。标题显示研究重点在重症监护学领域，可能结合呼吸力学参数与脑代谢监测指标进行综合分析。尽管缺乏摘要细节，但该研究有望为临床在通气策略中平衡脑灌注与氧合提供重要参考。若进一步明确样本特征与动态监测方法，其临床指导意义将更为显著。

---

## 6. 急性呼吸窘迫综合征的医学管理

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41428205)
**期刊：** Intensive care medicine
**PMID：** 41428205
**DOI：** 10.1007/s00134-025-08251-y

### 第一部分 原文与翻译

**英文原标题：** The medical management of acute respiratory distress syndrome.

> **英文摘要：**
> Despite advancements in bedside monitoring and paradigm shifts in standard ventilatory practice, mortality from acute respiratory distress syndrome (ARDS) remains high. The recent Global ARDS definition adopts a more pragmatic approach enabling earlier identification across a broader patient spectrum, independent of the interventions being administered. Meanwhile, our understanding of managing this heterogeneous syndrome has shifted towards defining precise subgroups with shared therapeutic targets. Physiological, biological, and radiological phenotypes may modify the response to interventions previously showing indeterminate benefit, making them potentially central to future personalised ARDS management. This narrative review summarises core evidence for the medical and ventilatory management of ARDS, explores emerging concepts, and offers clinicians a framework for current best practice and a roadmap for possible future directions.

> **中文摘要：**
> 尽管床旁监测技术不断进步，且常规通气策略经历了范式转变，急性呼吸窘迫综合征（ARDS）的死亡率仍然居高不下。最新的全球 ARDS 定义采取了更具实用性的方式，使得能够在更广泛的患者群体中更早识别该综合征，而不依赖正在实施的干预措施。同时，我们对这种异质性综合征的管理理解正在转向界定具有共同治疗靶点的精确亚群。生理学、生物学和影像学表型可能会调节先前获益不确定的干预措施的反应，从而可能成为未来个体化 ARDS 管理的核心。本综述总结了 ARDS 医学与通气管理的核心证据，探讨了新兴理念，并为临床医生提供了当前最佳实践框架及未来可能发展的路线图。

### 第二部分 AI 大师评价

本文旨在综述急性呼吸窘迫综合征（ARDS）的最新医学和机械通气管理进展，强调了新全球定义在早期识别和广泛适用性方面的意义。作者提出以生理、分子、生物影像等特征识别亚群，从而实现更精准的治疗路径。文章的创新性在于强调表型导向的个体化管理思路，为未来临床试验和治疗策略提供方向。其局限性在于主要为叙述性综述，缺乏定量证据验证所提概念。

---

## 7. 静-静脉体外膜氧合（VV-ECMO）撤机实践：国际重症医学学会（ESICM）认可的WEAN-ECMO调查研究。

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41428203)
**期刊：** Intensive care medicine
**PMID：** 41428203
**DOI：** 10.1007/s00134-025-08266-5

### 第一部分 原文与翻译

**英文原标题：** Weaning practices from veno-venous ECMO: the international ESICM-endorsed WEAN-ECMO survey.

> **英文摘要：**
> No abstract available.

> **中文摘要：**
> 无摘要可用。

### 第二部分 AI 大师评价

本研究旨在通过国际范围的WEAN-ECMO调查，系统评估静-静脉ECMO撤机的实际临床做法及差异。该工作由国际重症医学学会（ESICM）支持，强调临床实践模式的多样性及制定标准化撤机流程的重要性。虽然未提供摘要，但从题目可推测其价值在于建立共识并优化撤机决策流程，对重症支持治疗具有重要的参考意义。

---

## 8. M3 蛋白识别胶原蛋白的结构基础及其在生物膜形成中的作用

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41424245)
**期刊：** eLife
**PMID：** 41424245
**DOI：** 10.7554/eLife.105539

### 第一部分 原文与翻译

**英文原标题：** Structural basis for collagen recognition by the  M3 protein and its involvement in biofilm.

> **英文摘要：**
> The M protein is an essential virulence factor of , or group A streptococcus (GAS), one of the most common and dangerous human pathogens. Molecular and functional characterization of M protein variants and their interactions with host components is crucial for understanding streptococcal pathogenesis and vaccine development. The M3 protein is produced by the prevalent 3 GAS serotype, which is frequently associated with severe invasive diseases. Here, we structurally and biochemically characterize the interaction of M3 with human collagens. High-resolution structures of the N-terminal M3 domain in the free state as well as bound to a collagen peptide derived from the Collagen Ligands Collection reveal a novel T-shaped protein fold that presents binding sites complementing the characteristic topology of collagen triple helices. The structure of the M3/collagen peptide complex explains how 3 GAS and related streptococci, such as  subsp. , can target collagens to enable colonization of various tissues. In line with this, we demonstrate that the M3/collagen interaction promotes enhanced biofilm formation of 3 GAS in an  type-specific manner, which can be inhibited with the recombinant N-terminal M3 domain. Further, 3 GAS are shown to colocalize with collagen in tissue biopsies from patients with necrotizing soft tissue infections, where GAS biofilms are common. This observation is reproduced in infected organotypic skin models. Together, these data provide detailed molecular insights into an important streptococcal virulence mechanism with implications for the understanding of invasive infections, strategies for treating biofilm and M-protein-based vaccine design.

> **中文摘要：**
> M 蛋白是 A 组链球菌（GAS）的关键毒力因子之一，GAS 是最常见且最危险的人类病原菌之一。对 M 蛋白不同变体及其与宿主组分相互作用的分子和功能特征进行表征，对于理解链球菌致病机制及疫苗开发至关重要。M3 蛋白由流行的 3 型 GAS 产生，该血清型常与严重的侵袭性疾病相关。在本研究中，我们从结构和生化角度表征了 M3 与人源胶原蛋白之间的相互作用。高分辨率结构显示，自由状态下的 M3 N 末端结构域及其与来源于胶原配体库的胶原肽复合后的结构揭示了一种新的“T”形蛋白折叠，其结合位点与胶原三螺旋的特征拓扑结构相互补充。M3/胶原肽复合物的结构阐明了 3 型 GAS 及相关链球菌（如某些亚种）如何通过靶向胶原蛋白实现对多种组织的定植。与此一致，我们证明 M3 与胶原的相互作用可促进 3 型 GAS 以特异性方式增强生物膜形成，而重组的 M3 N 端结构域可抑制这一过程。此外，在坏死性软组织感染患者的组织活检中，3 型 GAS 被发现与胶原共定位，而此类感染中 GAS 生物膜十分常见。相同现象在感染的器官型皮肤模型中亦得到重现。总体而言，这些结果提供了关于一种重要链球菌毒力机制的详细分子见解，并对侵袭性感染的理解、生物膜治疗策略及基于 M 蛋白的疫苗设计具有重要意义。

### 第二部分 AI 大师评价

本文以结构生物学与生化分析为核心，解析了 M3 蛋白如何特异识别人源胶原及其在促进 GAS 生物膜形成中的机制。研究发现 M3 N 端具有新颖的“T”形折叠，为胶原三螺旋提供互补结合界面。通过体内外实验，作者进一步确认该相互作用促进菌株定植与生物膜构建，并可被重组蛋白阻断。该研究为理解链球菌侵袭性病理及开发 M 蛋白靶向疫苗提供了坚实的结构基础，但其局限在于尚需更多体内验证与临床相关性研究。

---

## 9. 受控循环性死亡后临终关怀与器官捐献中家属的经验：一项全国前瞻性多中心研究

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41423695)
**期刊：** Critical care (London, England)
**PMID：** 41423695
**DOI：** 10.1186/s13054-025-05807-8

### 第一部分 原文与翻译

**英文原标题：** Relatives' experiences of end-of-life care and organ donation after controlled circulatory death: a national prospective multicenter study.

> **英文摘要：**
> BACKGROUND: The development of controlled donation after circulatory determination (cDCDD) - a promising strategy to improve access to transplantation - raises unique ethical, relational and communication challenges. We aimed to evaluate the psychological outcomes and lived experiences of relatives of potential cDCDD donors.
> 
> METHODS: We conducted a prospective multicenter study in 32 French ICUs. Relatives of patients identified as potential cDCDD donors following a decision to withdraw life-sustaining measures (WLSM) were recruited. One relative per patient, preferentially the most involved in decision-making, was followed up by structured phone interviews at 3 and 6 months. Outcomes included PTSD symptoms (IES-R, primary endpoint), anxiety and depression (HADS), experience of dying and death (CAESAR), prolonged grief (PG-13), and a study-specific questionnaire on perceptions of end-of-life and organ donation (OD) processes. Two subgroups were defined: OD+, when WLSM was initiated while OD was still considered possible, and OD-, when OD was no longer considered at the time of WLSM.
> 
> RESULTS: A total of 159 relatives were included (119 OD+, 40 OD-). Follow-up was completed in 118 relatives at 3 months and 109 at 6 months. At 3 months, one third reported PTSD symptoms, half reported anxiety, and one third depression, with persistence at 6 months for a substantial proportion. Around 10% described a distressing experience of dying and death, and fewer than 10% met criteria for prolonged grief disorder. Psychological outcomes did not differ between OD + and OD - groups. Most relatives felt involved in WLSM and OD discussions, though 80% perceived being asked to authorize donation. Emotional responses were ambivalent, combining reassurance and distress.
> 
> CONCLUSION: Relatives of potential cDCDD donors experience high levels of psychological distress, but OD discussions did not exacerbate burden. These findings support that cDCDD can be implemented without additional risk for families, while underscoring the need for improved shared decision-making, communication, and emotional support in the ICU.
> 
> TRIAL REGISTRATION: ClinicalTrials.gov ID NCT05041023 (First registration date: 2021-09-02).

> **中文摘要：**
> 背景：受控循环死亡后捐献（cDCDD）的发展——一种有望改善移植供体获取的策略——带来了独特的伦理、人际关系及沟通挑战。本研究旨在评估潜在 cDCDD 捐献者家属的心理结局及其生活经历。
> 
> 方法：我们在法国32家重症监护病房开展了一项前瞻性多中心研究。纳入那些在决定撤除生命维持措施（WLSM）后被确定为潜在 cDCDD 捐献者的患者家属。每位患者选择一位家属参与，优先选择在决策过程中参与程度最高者。通过结构化电话访谈分别于3个月和6个月进行随访。结局指标包括创伤后应激障碍症状（IES-R，主要终点）、焦虑与抑郁（HADS）、临终与死亡体验（CAESAR）、延长性哀伤（PG-13），以及一份研究特定问卷以评估对临终和器官捐献（OD）过程的看法。定义了两个亚组：OD+ 组为在仍考虑器官捐献时启动 WLSM 的情况，OD− 组为在 WLSM 时不再考虑捐献的情况。
> 
> 结果：共纳入159名家属（OD+ 119人，OD− 40人）。3个月时完成随访者118人，6个月时109人。3个月时，约三分之一报告有 PTSD 症状，一半报告焦虑，三分之一报告抑郁，其中相当比例在6个月时仍持续。约10%报告临终与死亡经历令人痛苦，少于10%符合延长性哀伤障碍标准。OD+ 与 OD− 组间心理结局无显著差异。大多数家属感到自己参与了 WLSM 和 OD 的讨论，然而80%表示感受到被请求授权捐献。情感反应表现出矛盾性，既有安慰也伴随痛苦。
> 
> 结论：潜在 cDCDD 捐献者的家属普遍经历显著心理压力，但器官捐献讨论并未加重负担。本研究结果支持 cDCDD 可在不增加家庭风险的情况下实施，同时强调应加强 ICU 环境中的共同决策、沟通与情感支持。
> 
> 试验注册：ClinicalTrials.gov ID NCT05041023（首次注册日期：2021-09-02）。

### 第二部分 AI 大师评价

本研究通过全国性前瞻性多中心设计，首次系统评估了潜在 cDCDD 捐献者家属的心理影响和体验。结果显示，尽管家属普遍存在心理困扰，但器官捐献的沟通并未加重其负担，支持 cDCDD 在伦理和心理层面上的可行性。研究强调了在 ICU 环境中改进沟通与共同决策的重要性。其优势在于设计严谨、指标全面，但受限于观察性研究性质及随访样本流失，需进一步探索长期心理结局和干预策略。

---

## 10. 量化抗菌药物使用对马拉维成年人肠道微生物组和耐药基因组的旁观者效应

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41423629)
**期刊：** Nature communications
**PMID：** 41423629
**DOI：** 10.1038/s41467-025-67677-6

### 第一部分 原文与翻译

**英文原标题：** Quantifying the bystander effect of antimicrobial use on the gut microbiome and resistome in Malawian adults.

> **英文摘要：**
> Antibiotic treatment for sepsis has an unintended yet crucial consequence: it exerts a bystander effect on the microbiome, changing its bacterial composition and resistome. Antimicrobial stewardship aims, in part, to minimise this effect to prevent development of subsequent drug-resistant infection, but data evaluating and quantifying these changes are largely lacking, especially in low-income settings which are disproportionately affected by antimicrobial resistance. Such data are critical to creating evidence-based stewardship protocols. Here, we address this data gap in Blantyre, Malawi. We use longitudinal sampling of human stool and metagenomic deep sequencing to describe microbiome composition and resistome pre-, during- and post-antimicrobial exposure. We develop Bayesian regression models to link these changes to individual antimicrobial agents. We find that ceftriaxone, in particular, exerts strong off-target effects, both increasing abundance of Enterobacterales, and the prevalence of macrolide and aminoglycoside resistance genes. Simulation from the fitted models allows exploration of different stewardship strategies and can inform practice in Malawi and elsewhere.

> **中文摘要：**
> 针对脓毒症的抗生素治疗具有一个非预期但至关重要的后果：它对微生物组产生旁观者效应，改变其细菌组成和耐药基因组。抗菌药物管理的部分目标是尽量减少这种效应，以防止后续耐药感染的发生，但关于这些变化的评估和量化数据仍然严重缺乏，尤其是在受抗菌素耐药性不成比例影响的低收入地区。此类数据对于制定循证的抗菌药物管理方案至关重要。本研究在马拉维布兰太尔填补了这一数据空白。我们采用对人粪便的纵向采样和宏基因组深度测序来描述抗菌药物暴露前、期间及之后的微生物组组成和耐药基因组。我们建立贝叶斯回归模型，将这些变化与特定抗菌药物相关联。我们发现，尤其是头孢曲松具有明显的非靶向效应，不仅提高肠杆菌目细菌的丰度，还增加大环内酯类和氨基糖苷类耐药基因的流行程度。基于拟合模型的模拟可用于探索不同的抗菌药物管理策略，并为马拉维及其他地区的实践提供参考。

### 第二部分 AI 大师评价

本研究旨在量化抗菌药物使用对马拉维成人肠道微生物组与耐药基因组的旁观者效应，弥补低收入地区相关数据的不足。研究者通过纵向粪便采样结合宏基因组测序，利用贝叶斯回归模型揭示不同抗菌药物尤其是头孢曲松的非靶向影响。结果显示，该药显著促进了潜在耐药菌群和耐药基因的扩增。研究创新在于以定量建模方法揭示药物使用的全身生态影响，但局限在于样本地域集中于单一城市，外推广适性尚待验证。

---

## 11. 机械通气患者的气道开放压：区域分布及体位影响

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41423600)
**期刊：** Critical care (London, England)
**PMID：** 41423600
**DOI：** 10.1186/s13054-025-05809-6

### 第一部分 原文与翻译

**英文原标题：** Airway opening pressure in mechanically ventilated patients: regional distribution and impact of body position.

> **英文摘要：**
> No abstract available.

> **中文摘要：**
> 无可用摘要。

### 第二部分 AI 大师评价

本研究旨在探讨机械通气患者的气道开放压在不同肺部区域的分布特征，以及体位变化对气道开放压的影响。该主题与重症监护中肺保护性通气策略的优化密切相关，可能涉及利用影像学或压力测量方法评估肺部不同区域的力学差异。尽管暂无摘要限制了对研究方法与结果的深入了解，但题目表明作者关注区域性肺力学差异与体位管理的重要性，其潜在价值在于指导个体化通气设定与改善氧合策略。

---

速递结束，祝您工作愉快！